Suppression of gastric acid with intravenous esomeprazole and omeprazole: results of 3 studies in healthy subjects.
1. 系统已在2025-05-27 18:11:49对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
K Röhss, C Wilder-Smith, J Kilhamn…
… journal of clinical …, 2007
europepmc.org
Objective To identify the optimal pharmacodynamic dosing regimen for esomeprazole administered intravenously (iv) and to compare acid suppression with various esomeprazole iv and omeprazole iv dosing regimens. Methods A total of 90 healthy Helicobacter pylori-negative subjects participated in three randomized, crossover studies of esomeprazole iv Comparative acid output study: an open-label study that compared single 40 mg iv doses (administered over 30 min) of esomeprazole and omeprazole. Dose-ranging study: an open …
